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Introduction
There are many different methods used for embryo
transfer as an assisted reproductive technique, ranging
from the gamete intrafallopian transfer (GIFT) to today’s
day 5 blastocyst uterine transfer. Besides the quality of
the embryo, the implantation and pregnancy rates are
also dependent on the method of embryo transfer.
The timing and position of embryo transfer are very
important. One of the methods, day 2 tubal embryo
transfer (TET) is less commonly practiced; thus, there
are few studies comparing the success rates of TET and
embryo transfer into the uterus (ET). A meta-analysis of
the randomized controlled studies reviewed by Tournaye
et al indicates no benefit of intratubal transfer proce-
dures over intrauterine transfers [1]. However, the data
compared in that study was between GIFT or zygote
intrafallopian transfer (ZIFT) and day 2 ET. The aim of
this retrospective study is to compare implantation
and pregnancy rates between TET performed on the
2nd day and ET performed on the 3rd day following
intracytoplasmic sperm injection (ICSI) in couples with
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SUMMARY
Objective: To compare the results of embryo transfer into the uterus (ET) performed on day 3 vs. tubal embryo
transfer (TET) on day 2 in couples diagnosed with male factor infertility.
Materials and Methods: We collected data from 34 and 110 patients who underwent intracytoplasmic sperm
injection (ICSI) followed by either TET on day 2 or ET on day 3 (January 2001–June 2005), respectively. All cou-
ples were diagnosed with male factor infertility; there were no tubal or uterine factors, diminished ovarian
reserve, pelvic adhesions, history of polycystic ovary syndrome or previous ovarian surgery.
Results: The clinical pregnancy rates of day 2 TET and day 3 ET following ICSI were 64.71% and 57.27%
(p > 0.05), respectively. The corresponding implantation rates were 35.47% and 29.58% (p > 0.05), respec-
tively.
Conclusion: The implantation and clinical pregnancy rates of ET on the 3rd day following ICSI were similar to
the rates obtained with TET 2 days after ICSI. Therefore, ET performed 3 days after ICSI should be the first
choice for couples with male factor infertility, while day 2 TET remains a good alternative, especially for women
with normal tubal function and known difficulties of transcervical ET. [Taiwanese J Obstet Gynecol 2006;
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male factor infertility, in an effort to exclude the con-
founding effects of varied etiologies of infertility.
Materials and Methods
Patients
All couples underwent infertility evaluation and treat-
ment between January 2001 and June 2005. All female
participants had patent fallopian tubes confirmed by
hysterosalpingography and/or laparoscopy. Women
over 40 years of age and those who had a uterine factor,
diminished ovarian reserve, pelvic adhesive disease, a his-
tory of polycystic ovary syndrome or prior ovarian surgery
were excluded from this study. All couples underwent
in vitro fertilization with ICSI as treatment for male factor
infertility. We collected data from 34 and 110 patients
who underwent ICSI followed by TET 2 days after ovum
retrieval and ET 3 days after ovum retrieval, respectively.
Semen analysis was performed according to World
Health Organization guidelines with regard to sperm
concentration, motility and morphology. For sperm mor-
phology, we used the strict criteria as described by Kruger
et al [2,3]. Male factor infertility was defined by the
presence of any of these parameters: sperm concentra-
tion < 20 × 106/mL, motility < 50% and normal mor-
phology < 4% under Kruger’s criteria. Men with < 4%
normal forms have “a poor prognosis pattern” group
in terms of fertilization rate [4–6].
Ovarian stimulation protocol and 
embryo transfer procedures
All patients underwent the same ovarian hyperstimu-
lation protocol. Subcutaneous injection of leuprolide
acetate (Lupron; Abbott Laboratories, Chicago, IL, USA)
for pituitary desensitization was started on the 20th day
of the previous menstrual cycle and continued daily
until the administration of human chorionic gonado-
tropin (HCG) (Pregnyl; Organon, Oss, The Netherlands).
Gonadotropins, a combination of human menopausal
gonadotropins (HMG) (Pergonal; Serono, Rome, Italy)
and recombinant follicle stimulating hormone (r-FSH)
(Gonal-F; Serono, Aubonne, Switzerland), were adminis-
tered intramuscularly from the 3rd day of the menstrual
cycle. The doses of r-FSH and HMG used were adjusted
depending on the individual’s ovarian response to stim-
ulation. Starting on the 7th day of the menstrual cycle,
transvaginal ultrasonography was used to monitor
follicular growth. When two or three dominant follicles
reached a mean diameter of 19 mm, ovulation was
induced with 10,000 IU of HCG. Transvaginal ovum
pick-up (OPU) was performed under ultrasonographic
guidance 34–36 hours later.
After OPU, luteal phase support was provided with
an intramuscular injection of 2,500 IU HCG on days 2,
5 and 8, or a daily intramuscular injection of 50 mg
progesterone (Tai Yu Chemical Pharmaceutical Co.,
Shing Ju, Taiwan). Vaginal application of micronized pro-
gesterone (Utrogestan; Laboratories Piette International
S.A., Brussels, Belgium) at a dose of 600 mg/day was
also administered beginning on the 2nd day after OPU.
For TET, each patient underwent laparoscopy 2
days following ICSI. In each case, the appearance of
both tubes was normal. A GIFT catheter (k-GIFT-1010;
COOK, Queensland, Australia) was used to transfer
embryos in 20 μL of G1.2 medium (Vitrolife AB,
Gothenburg, Germany). All embryos were transferred
into either the right tube and/or the left tube, with the
transfer bolus deposited approximately 2–4 cm from
the fimbria. The entire process was continuously moni-
tored laparoscopically, and was atraumatic in all
cases. For the uterine transfer group, embryos were
transferred 3 days following ICSI into the uterine cavity
using an intracervical catheter. Embryos were intro-
duced into the uterine cavity through the inner catheter
after the outer catheter had passed the internal cervical
os. Following TET and ET, all patients remained in the
supine position for 4 hours.
An intrauterine gestational sac visualized on ultra-
sound examination 3.5 weeks after embryo transfer was
considered to be a clinical pregnancy. Implantation rate
was defined as the proportion of individual embryos
transferred that resulted in a gestational sac. We used
the classification for embryo assessment introduced by
Veeck [7]. The blood estradiol (E2) level on the day of
HCG injection, number of oocytes retrieved, number
of mature oocytes generated, number of fertilized
oocytes, number of embryos formed and number of
embryos transferred were all measured.
Statistical analysis
The data are presented as mean ± standard deviation.
Comparisons between the two groups were performed
using the Mann–Whitney U test. The χ2 analysis was
used to analyze clinical pregnancy rates. A p value  less
than 0.05 was considered statistically significant.
Results
The comparison of outcomes between TET performed
on the 2nd day and ET on the 3rd day following oocyte
retrieval is shown in the Table. There were no signifi-
cant differences between the mean ages, mean E2 level
on the day of HCG administration, number of oocytes
retrieved, oocyte maturation rate, fertilization rate, or
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3232
T.F. Lee, et al
the number of embryos transferred between the two
groups. The clinical pregnancy rates were 64.71% and
57.27% in the day 2 TET group and the day 3 ET
group, respectively, and the implantation rates were
35.39% and 29.58%, respectively; neither difference
was statistically significant.
Discussion
Day 2 TET was a common procedure used in Taiwan
in the past. In general, it is currently believed that the
outcomes of day 2 TET are better than day 2 ET [8–10],
and the outcomes of day 3 ET are better than day 2 ET
[11–13]; thus, we  were interested in comparing the out-
comes of day 2 TET and day 3 ET. In the present study,
we enrolled young couples who had only male factor
infertility in order to exclude any potential confounding
effects arising from varied etiologies of infertility.
During earlier studies, it was theorized that embryo
transfer to the fallopian tube was better than direct
placement into the uterus on day 2 for the following
reasons: (1) the quality of the culture medium is not
adequate, so it was believed that the early cleaved
embryo developed better in the fallopian tube than in
culture medium; (2) embryo transfer to the tube will itself
mediate entry of the embryo into the uterine cavity at the
correct time, which may improve chances of implanta-
tion [14]; and (3) there has been speculation that during
ET, the introduction of a catheter may adversely alter the
endometrial milieu [15]. As for TET, the embryo enters
the uterine cavity in a physiologic manner. Most impor-
tantly, the presence of numerous growth factors and
cytokines in human tubal fluid may contribute to the
development of the early embryo, i.e. all factors may
enhance implantation [16]. The role of the fallopian tube
could be not only mechanical (allowing embryo trans-
port), but also metabolically active in providing nutrients.
As to the outcome of day 3 ET being better than day
2 ET, there are some possible explanations for this obser-
vation. First, the timing of ET on the 3rd day is closer to
the physiologic time of embryo entry into the uterine
cavity, i.e. the timing of the arrival of embryos in the
uterus is at the morula stage, which is 4–5 days after ovu-
lation [17]. Second, prolonged embryo culture provides
a greater opportunity to monitor embryo development
and assess embryo quality. Although there may be
many quality embryos on day 2, the quality may not
necessarily be maintained by day 3 as the development
of embryos can slow down or arrest. Thus, day 3 ET pro-
vides a better opportunity to select embryos with better
qualities to transfer. Third, the level of certain growth
factors such as leukemia inhibitory factor, colony-
stimulating factor-1, glycodelin and integrin αvβ3
increases greatly during the implantation window,
which would facilitate implantation [18]. Such growth
factors participate in a synchronized manner between
the endometrium and the preimplanting embryo, i.e.
once the embryo has reached the uterine cavity, a pre-
programmed sequence of events occurs. These steps
involve the production and secretion of many bio-
chemical factors such as cytokines, growth factors and
adhesion molecules by the endometrium as well as the
embryo, thus leading to the formation of a receptive
endometrium. The above events signify the importance
of the timing in which the embryo is implanted into
the uterus. Since these factors are secreted in a greater
amount on the 3rd rather than the 2nd day, in theory,
the outcome of ET should be superior on the 3rd day.
In our study, we clearly demonstrated that the
implantation and pregnancy rates are similar when ET
is performed on the 3rd day vs. when TET is performed
on the 2nd day following oocyte retrieval. Even though
the fallopian tube milieu is the best for gamete survi-
val and embryo development and far better than the
suboptimal conditions developed in artificial culture
Table. Comparison of outcomes of tubal embryo transfer (TET) on day 2 and embryo
transfer into the uterus (ET) on day 3 (January 2001–June 2005)
Day 2 TET Day 3 ET p
Number of cycles 34 110
Age of woman (yr) 32.09 ± 3.55 32.76 ± 3.98 NS
E2 (pg/mL) on day of HCG 2,601.20 ± 1,328.43 2,533.38 ± 1,784.71 NS
Number of oocytes retrieved 10.97 ± 4.21 11.94 ± 7.08 NS
Maturation rate (%) 92.50 89.13 NS
Fertilization rate (%) 79.03 75.82 NS
Number of transferred embryos 3.41 ± 0.82 2.98 ± 1.23 NS
Implantation rate (%) 35.47 29.58 NS
Clinical pregnancy rate (%) 64.71 57.27 NS
E2 = estradiol; HCG = human chorionic gonadotropin; NS = not significant.
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media, today’s culture media technologies are advanced
enough for embryos to develop into the blastocyst stage,
overcoming the difficulties presented by the use of pre-
vious generations of culture media. Thus, in the present
study, we found that the outcome of TET on day 2 is
similar to that of ET on day 3. Furthermore, in recent
years, we have predominantly more day 3 ET cases
than TET cases, thus limiting our study.
It is very important that embryo transfer is done at
the right time and in the right site. Differences in the
production of factors modulating embryonic growth
and invasiveness of the predecidualized endometrium
could justify possible differences in embryo implanta-
tion between the uterine cavity and the tubal transfer of
embryos. The choice of methods for embryo transfer can
be made on the basis of infertility factors, chance for suc-
cess, cost and risk. The only contraindication to perform-
ing TET is the absence of functioning fallopian tubes. A
disadvantage of TET (compared with ET) is the need for
laparoscopy under general anesthesia, which increases
the total cost as well as risk to the patient. Taken toge-
ther, we believe that day 3 ET is the optimal choice.
In conclusion, this study demonstrates that the
implantation and clinical pregnancy rates of TET on day
2 are the same as that of ET on day 3. Therefore, day 3
ET should be the first choice for couples with male fac-
tor infertility. TET on day 2 remains a good alternative,
especially for patients with good tubal function and
known difficulties of transcervical ET.
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